Protocol 402-C-1808: A Phase 3 Trial of the Efficacy and Safety of Bardoxolone Methyl in Patients with Autosomal Dominant Polycystic Kidney Disease

Project: Research project

StatusActive
Effective start/end date7/24/197/24/22

Funding

  • Reata Pharmaceuticals, Inc. (Protocol 402-C-1808)